77
Participants
Start Date
April 30, 2007
Primary Completion Date
August 31, 2007
Study Completion Date
SRX251
Advanced Biomedical Research, Inc., Hackensack
Lead Sponsor
Azevan Pharmaceuticals
INDUSTRY